MedTrace Logo

Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY)

NCT00295191 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 704

Last updated 2011-10-04

No results posted yet for this study

Summary

This study aims to investigate the effects of high flux dialyser use and ultra pure dialysate utilization on cardiovascular disease by evaluating cardiovascular morbidity and mortality, progression of carotid artery intima-media thickness and coronary artery calcifications, inflammatory state, lipid levels, nutritional status, and erythropoietin requirement in hemodialysis patient population. It is hypothesized that both interventions in this project may diminish cardiovascular disease in hemodialysis patients.

Conditions

  • End-stage Renal Disease
  • Hemodialysis

Interventions

PROCEDURE

high-flux membrane

high-flux dialyser

PROCEDURE

low-flux membrane

low-flux dialyser

PROCEDURE

conventional dialysate

conventional dialysate

PROCEDURE

ultrapure dialysate

ultrapure dialysate

Sponsors & Collaborators

  • Fresenius Medical Care North America

    collaborator INDUSTRY

  • Ege University

    lead OTHER

Principal Investigators

  • Ercan Ok, M.D · Ege University School of Medicine Nephrology Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00295191 on ClinicalTrials.gov